Webinar: Miniaturization of Freeze Drying: Process Optimization in the LyoCapsule Using Innovative PAT
Can't see this email? View it online
   
  January 18, 2019  
  Pharmacy / Pharmacology  
  The latest pharmacy / pharmacology news from News Medical  
 

#ALT# Webinar: Miniaturization of Freeze Drying: Process Optimization in the LyoCapsule Using Innovative PAT

Join SP Scientific on the 24th January for their free online webinar focusing on the applicability of MTM and SMART™ in the LyoCapsule™ freeze dryer in miniaturization of freeze drying, especially in early development phases. Miniaturization in freeze drying is a relevant topic due to the limited availability and costs of API, especially in early development phases. A mini-freeze dryer (LyoCapsule™) consists of a small cylindrical inner chamber intended to freeze dry a reduced number of vials (typically seven 20R vials) and utilizes wall temperature control to emulate heat and mass transfer conditions typically encountered in larger scale.

Register Now
 
   GC-MS for Biomarker DiscoveryGC-MS for Biomarker Discovery
 
A substantial fraction of research investigations are concentrated on apprehending, diagnosing and preventing human diseases, and recently attention has shifted towards biomarker discovery. A method that combines gas chromatography (GS) and mass spectrometry (MS) for this purpose can easily identify the presence of different substances in a sample.
 
   Study raises hopes for new approaches to treat osteoporosisStudy raises hopes for new approaches to treat osteoporosis
 
A handful of brain cells deep in the brain may play a surprising role in controlling women's bone density, according to new research by UC San Francisco and UCLA scientists.
 
 What are Bispecific Monoclonal Antibodies?
 
What are Bispecific Monoclonal Antibodies?Bispecific antibodies are artificial proteins that have promising applications in the field of cancer immunotherapy. They are comprised of two monoclonal antibodies held together by a flexible peptide linker. As the name suggests, this makes them able to bind to two different antigens.
 
 
 Researchers identify promising therapeutic option to treat multiple sclerosis
 
Researchers identify promising therapeutic option to treat multiple sclerosisWith funding provided by the German Research Foundation (DFG) for the Collaborative Research Center/Transregio 128, researchers at the Medical Center of Johannes Gutenberg University Mainz (JGU) identified an innovative and promising therapeutic option to treat multiple sclerosis.
 
 
 Scientists discover a dramatic pattern of bone growth in female mice
 
Scientists discover a dramatic pattern of bone growth in female miceUCLA and UC San Francisco life scientists have discovered a dramatic pattern of bone growth in female mice -- research that could potentially lead to stronger bone density in women and new treatments for osteoporosis in older women.
 
 
 UC San Diego to conduct first U.S. clinical trial of intravenously administered bacteriophage therapy
 
UC San Diego to conduct first U.S. clinical trial of intravenously administered bacteriophage therapyThe U.S. Food and Drug Administration has accepted an Investigational New Drug application by physician-scientists at University of California San Diego School of Medicine to conduct the first U.S. clinical trial of an intravenously administered bacteriophage-based therapy.